Fondation Ophtalmologique A. de Rothschild
Paris, France
NCT Number: NCT03326908
Improvement of retinal medical imaging opens new perspectives for exploring the retinal structures. Optical coherence spectral domain (SD-OCT), which has been widely used in the last ten years, is certainly the most advanced device. In the analysis of patients without retinal disease using SD-OCT, granulations in the interdigitation area were observed. These granulations have never been described with this device. They could correspond either to the degradation products of the external segments of the photoreceptors or to melanosomes. A descriptive study of these granulations at different examination times and in different lighting situations would allow us to obtain essential information for a better understanding of this area. Based on the results, larger studies could explore this area more finely in retinal pathologies involving dysfunctions of photoreceptors or of the pigmentary epithelium.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Five SD-OCTs will be performed with various conditions of enlightenment.
Time frame: 1 hour after baseline
Fondation Ophtalmologique Adolphe de Rothschild
Network
Description of the Interdigitation Retinal Area by SD-OCT (Spectral Domain Optical Coherence Tomography): An Exploratory Study (ODIGIT)
Acronym: ODIGIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05663333
Arteritis, Autoimmune Diseases
Chalon-sur-Saône, Saône-et-Loire, France
View Trial DetailsNCT05608902
Basal Cell Carcinoma, Carcinoma
Chalon-sur-Saône, Saône-et-Loire, France
View Trial DetailsNCT05635136
Kidney Transplantation, Tomography, Optical Coherence
Chalon-sur-Saône, Saône-et-Loire, France
View Trial DetailsNCT03268096
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Paris, France
View Trial Details